Interview With Janssen Doctor Explores Potential Bladder Cancer

By A Mystery Man Writer

Every year, roughly 80,000 Americans receive a bladder cancer diagnosis. Many endure difficult and burdensome treatments in an attempt to fight the disease. But new innovations just might change that.

Understanding the current medical landscape of prostate cancer

Johnson & Johnson Innovative Medicine on LinkedIn: In Conversation With Sylvie Laquerre, Ph.D., Janssen Oncology

Frontiers The Evolving Clinical Management of Genitourinary Cancers Amid the COVID-19 Pandemic

Advances in immunotherapies and targeted treatments for patients

Paradigm Shift in Bladder Cancer? Phase 3 Trials May Expand Nonsurgical Options

Jahresbericht MOH 2020-2021 by Universitätsspital Zürich - Issuu

Is it possible to cure bladder cancer?

Advances in immunotherapies and targeted treatments for patients with bladder cancer: An update from ESMO 2022 - touchONCOLOGY

Paige and Janssen Deploy AI Based Biomarker Test For Bladder Cancer

Advances in immunotherapies and targeted treatments for patients

Paige and Janssen Deploy AI Based Biomarker Test For Bladder Cancer

Paige and Janssen Deploy AI Based Biomarker Test For Bladder Cancer

Janssen's global head of R&D opens up on CAR-T research, data science and more - Drug Discovery and Development